*Note: Doses requiring more than 100 units may require two separate injections if using a 1 mL syringe
In a Phase II clinical trial targeting patients with obesity, Danuglipron showcased significant weight loss effects over a 32-week treatment period
GLP-1 Compounding: When Innovation May Mean Liability As previously reported on our blog, the rise of compounded GLP-1 medications has sparked both excitement and concern across the healthcare and legal landscapes
In initial validation analyses, we documented that consumption of a high-fat diet (HFD) overtly exacerbated the metabolic profile of PWA animals (Suppl
Defects in complex I are among the most common causes of mitochondrial diseases, contributing to disorders such as Leigh syndrome, mitochondrial encephalomyopathy and Parkinsons disease by disrupting ATP production and elevating oxidative stress 21,71,72,73